BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37545272)

  • 21. MiR-524-5p Suppresses Migration, Invasion, and EMT Progression in Breast Cancer Cells Through Targeting
    Jin T; Zhang Y; Zhang T
    Cancer Biother Radiopharm; 2020 Dec; 35(10):789-801. PubMed ID: 32298609
    [No Abstract]   [Full Text] [Related]  

  • 22. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-216a-5p act as a tumor suppressor, regulating the cell proliferation and metastasis by targeting PAK2 in breast cancer.
    Zhang Y; Lin P; Zou JY; Zou G; Wang WZ; Liu YL; Zhao HW; Fang AP
    Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2469-2475. PubMed ID: 30964173
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

  • 25. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
    Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
    Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
    [No Abstract]   [Full Text] [Related]  

  • 26. MiR-16-5p suppresses breast cancer proliferation by targeting ANLN.
    Wang Z; Hu S; Li X; Liu Z; Han D; Wang Y; Wei L; Zhang G; Wang X
    BMC Cancer; 2021 Nov; 21(1):1188. PubMed ID: 34743685
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1.
    Lv M; Mao Q; Li J; Qiao J; Chen X; Luo S
    Cell Mol Biol Lett; 2020; 25():43. PubMed ID: 32983239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MiR-577 suppresses epithelial-mesenchymal transition and metastasis of breast cancer by targeting Rab25.
    Yin C; Mou Q; Pan X; Zhang G; Li H; Sun Y
    Thorac Cancer; 2018 Apr; 9(4):472-479. PubMed ID: 29524309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of miR-202-5p silencing PIK3CA gene expression on proliferation, invasion, and epithelial-mesenchymal transition of cervical cancer SiHa cells through inhibiting PI3K/Akt/mTOR signaling pathway activation.
    Zheng Y; Xie L; Xu S; Yan W; Zhang H; Meng Y; Liu J; Wei X
    Mol Cell Biochem; 2021 Nov; 476(11):4031-4044. PubMed ID: 34244973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.
    Yuan JH; Li WX; Hu C; Zhang B
    Neoplasma; 2020 Jul; 67(4):861-870. PubMed ID: 32386479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-508-5p serves as an anti-oncogene by targeting S100A16 to regulate AKT signaling and epithelial-mesenchymal transition process in lung adenocarcinoma cells.
    Wu C; Yang J; Lin X; Li R; Wu J
    Am J Med Sci; 2023 Jun; 365(6):520-531. PubMed ID: 36967030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Exosome miR-134-5p restrains breast cancer progression via regulating PI3K/AKT pathway by targeting ARHGAP1.
    Yang C; Zhang G; Zhang Y; Zhang S; Li J; Liu Y
    J Obstet Gynaecol Res; 2021 Nov; 47(11):4037-4048. PubMed ID: 34378285
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting TRIM9 by miR-218-5p Restricts Cell Proliferation and Epithelial-Mesenchymal Transition in Non-Small Cell Lung Cancer.
    Wang Z; Wang B; Wang K
    Ann Clin Lab Sci; 2023 Jan; 53(1):106-115. PubMed ID: 36889762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-122-5p promotes aggression and epithelial-mesenchymal transition in triple-negative breast cancer by suppressing charged multivesicular body protein 3 through mitogen-activated protein kinase signaling.
    Wang Z; Wang X
    J Cell Physiol; 2020 Mar; 235(3):2825-2835. PubMed ID: 31541468
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p/paired box 6 axis.
    Lin Q; Qi Q; Hou S; Chen Z; Jiang N; Zhang L; Lin C
    Bioengineered; 2021 Dec; 12(2):10136-10149. PubMed ID: 34866540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-217-5p suppresses epithelial-mesenchymal transition and the NF-κB signaling pathway in breast cancer via targeting of metadherin.
    Yang L; Liu S; Yang L; Xu B; Wang M; Kong X; Song Z
    Oncol Lett; 2022 May; 23(5):162. PubMed ID: 35399330
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MiR-4262 inhibits the development of esophageal cancer by negatively regulating KLF6 level.
    Liu Z; Zhao C; Du S; Gao S; Lu L
    Exp Mol Pathol; 2020 Aug; 115():104476. PubMed ID: 32473153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long Non-coding RNA LINC00473 Promotes Breast Cancer Progression
    Zhang C; Yang T
    Protein Pept Lett; 2023; 30(1):72-84. PubMed ID: 36305147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeting the Notch1 oncogene by miR-139-5p inhibits glioma metastasis and epithelial-mesenchymal transition (EMT).
    Li J; Li Q; Lin L; Wang R; Chen L; Du W; Jiang C; Li R
    BMC Neurol; 2018 Aug; 18(1):133. PubMed ID: 30170559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MiR-455-5p suppresses PDZK1IP1 to promote the motility of oral squamous cell carcinoma and accelerate clinical cancer invasion by regulating partial epithelial-to-mesenchymal transition.
    Hsiao SY; Weng SM; Hsiao JR; Wu YY; Wu JE; Tung CH; Shen WL; Sun SF; Huang WT; Lin CY; Chen SH; Hong TM; Chen YL; Chang JY
    J Exp Clin Cancer Res; 2023 Feb; 42(1):40. PubMed ID: 36737832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.